Jared Jagdeo
Procedural Dermatology · Brooklyn, NYNPI 1992983456
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $254,653 of the $362,232 with a category attached, or 70.3%. 33 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 26.5% of the total. Among procedural dermatology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 687 payments — averaging $527.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$96K
- Galderma Laboratories, L.p.$66K
- DUSA Pharmaceuticals, Inc.$49K
- Dermira, Inc.$40K
- Regeneron Healthcare Solutions, Inc.$34K
- Sanofi$21K
- plus $56K from 27 others
Across 9 payments — averaging $28,645 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$165K
- Sun Pharmaceutical Industries Inc.$92K
- Regeneron$981
What the payments were for
- Consulting fees$38,13511%
- Speaking & faculty fees$254,65370%
- Travel & lodging$39,17711%
- Food & beverage$30,1628%
- Education$1050%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 106 | $95,826 |
| Galderma Laboratories, L.p. | 72 | $66,001 |
| DUSA Pharmaceuticals, Inc. | 34 | $49,377 |
| Dermira, Inc. | 35 | $39,890 |
| Regeneron Healthcare Solutions, Inc. | 57 | $33,941 |
| Sanofi | 31 | $20,800 |
| Organon | 24 | $20,514 |
| E.r. Squibb & Sons, L.L.C. | 54 | $8,858 |
| Dermavant Sciences, Inc. | 40 | $8,015 |
| Pfizer | 17 | $7,398 |
| Johnson & Johnson | 29 | $2,335 |
| AbbVie(2 entities) | 43 | $2,241 |
| Merz North America, Inc. | 11 | $1,151 |
| UCB, Inc. | 20 | $874 |
| Lilly USA, LLC | 17 | $835 |
| Janssen Scientific Affairs, LLC | 8 | $814 |
| Mallinckrodt Hospital Products Inc. | 16 | $599 |
| Arcutis Biotherapeutics, Inc. | 18 | $592 |
| Novartis | 13 | $470 |
| Nobelpharma America, LLC | 9 | $448 |
| Biofrontera Inc. | 6 | $275 |
| Sanofi-aventis U.S. LLC | 5 | $268 |
| LEO Pharma Inc. | 5 | $154 |
| Regeneron | 2 | $138 |
| Incyte Corporation | 4 | $86 |
| Blueprint Medicines Corporation | 2 | $83 |
| Botanix SB Inc | 2 | $73 |
| Kyowa Kirin, Inc. | 2 | $48 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Boehringer Ingelheim | 1 | $25 |
| Chiesi USA, Inc. | 1 | $19 |
| Aclaris Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$362,232 in reported general payments places this provider in the 95th percentile of 69 procedural dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $47,402 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Brooklyn
- Marvin SnowBrooklyn$644
- H Eliot Y GhatanBrooklyn$175
- Joseph SchwartzTroy$470K
- Michelle HenryNew York$460K
- Jerry ShapiroNew York$414K
- Dendy EngelmanNew York$292K
- Evan RiederNew York$210K
- Daniel Belkin-HollandNew York$208K
- Suzanne Sirota-RozenbergWoodmere$122K
- Robert BacigalupiGarden City$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.